Skip to main content
. Author manuscript; available in PMC: 2010 Oct 11.
Published in final edited form as: Transplantation. 1998 Nov 27;66(10):1395–1398. doi: 10.1097/00007890-199811270-00024

TABLE 2.

Mean Treatment
group
Pre-LTxa PostLTx days

7 14 27 28 60 90 180 270 360
Renal function
  BUN (mg/dl) Double 21 52 56 51 45 29 28 29 26 23
Triple 22 45 45 49 44 28 24 27 26 23
  Creatinine (mg/dl) Double 1.26 1.77 2 2.1 2.1 1.41 1.37 1.37 1.47 1.39
Triple 1.32 1.55 1.6 1.8 1.6 1.44 1.31 1.38 1.46 1.42
Hematology
  Anemia % (Hct<25%) Double 12 14 25 19 22 9 4 4 0 3
Triple 13 12 15 20 22 7 6 2 2 0
  Leukopenia % (WBC<4.000/mm3 Double 24 0 6 0 4 17 15 22 14 22
Triple 31 4 3 9 9 20 27 20 22 20
  Thrombocytopenia % (platelets<50.000/mn3 Double 24 20 12 3 2 2 4 2 0 3
Triple 25 25 5 4 6 3 3 2 2 8
Baseline immunosuppression
  Tacrolimus dose (mg/day) Double 8.4 9.5 10.5 9.9 8.6 8.2 7.2 5.7 5.3
Triple 9.2 10.8 9.6 9.2 8 8 6.9 6.5 5.3
  Tacrolimus level (ng/ml) Double 15.8 14.5 15.3 14.5 11.9 12.2 11.1 10.1 10.6
Triple 15.1 14.2 13.9 14.2 11.8 11.6 11.5 10.6 10.7
  Prednisone (mg/day) Double 20 18.6 16.1 14.2 10 18.7 5.7 4.6 3.3
Triple 20 18.3 15.6 13.2 9.1 7.2 5.3 3.6 2
a

Abbreviation used in table: LTx, liver transplantation.